SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla reports 30% rise in Q4 consolidated net profit

13 May 2025 Evaluate

Cipla has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported 51.26% jump in its net profit at Rs 1485.40 crore for the quarter under review as compared to Rs 982.03 crore for the same quarter in the previous year. Total income of the company increased by 11.28% at Rs 5091.26 crore for Q4FY25 as compared Rs 4575.27 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 30.29% rise in its net profit at Rs 1214.14 crore for fourth quarter ended March 31, 2025 as compared to Rs 931.87 crore for the same quarter in the previous year. The total income of the company increased by 9.46% at Rs 7019.15 crore for Q4FY25 as compared Rs 6412.57 crore for the corresponding quarter previous year. 

For the year ended March 31, 2025, the company has reported 38.86% rise in its net profit at Rs 5157.65 crore as compared to Rs 3714.19 crore for the previous year. The total income of the company increased by 13.51% at Rs 20029.57 crore for year under review as compared to Rs 17645.00 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported 26.85% rise in its net profit at Rs 5269.20 crore as compared to Rs 4153.72 crore for the previous year. The total income of the company increased by 7.12% at Rs 28409.49 crore for year under review as compared to Rs 26520.66 crore for year ended March 31, 2024.

Cipla Share Price

1228.90 -9.40 (-0.76%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×